Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01941563 · ClinicalTrials.gov registry record · Phase 3

A Study of SI-6603 in Patients With Lumbar Disc Herniation

A Phase 3 study, sponsored by Seikagaku Corporation.

Completed
Registry status
Phase 3
Development phase
385
Enrollment target

NCT01941563: Completed Phase 3 study, sponsored by Seikagaku Corporation.

NCT01941563 is a Phase 3 study that has completed, run by Seikagaku Corporation. The registered enrollment target is 385 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01941563, a Phase 3 study, has completed, sponsored by Seikagaku Corporation.

COMPLETED
Registry status
Phase 3
Development phase
385 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.

Primary Outcome

Assessed by Visual Analog Scale (VAS)

Interventions

  • DRUG placebo
  • DRUG Condoliase

Trial Details

FieldValue
Enrollment Target 385 participants
Start Date 2013-09
Est. Completion 2017-08
Phase Phase 3
Seikagaku Corporation

12 total trials

What the finished NCT01941563 record still lists

NCT01941563 is an interventional study that assigns participants to a tested intervention. The registered 385 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (50% lower).

The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.

NCT01941563 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01941563 about?

NCT01941563 is a clinical study titled "A Study of SI-6603 in Patients With Lumbar Disc Herniation". The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.

What is the current status of trial NCT01941563?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 385 participants. The study started on 2013-09. Estimated completion is 2017-08.

What interventions are being tested in trial NCT01941563?

The interventions under investigation include: placebo (DRUG), Condoliase (DRUG).

Who is sponsoring clinical trial NCT01941563?

This trial is sponsored by Seikagaku Corporation, which has 12 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01941563's enrollment target sits among peer trials

385 975th of 2000 higher than 1,026 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05373823 · 385 participants · NA

    MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors

  • NCT05503173 · 385 participants · NA

    Telehealth for Pain and Unhealthy Drinking Among PLWH

  • NCT06226883 · 385 participants · Phase 2

    A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  • NCT06290063 · 385 participants · Phase 2

    Cannabidiol and Older Adult Cannabis Users

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01941563, the US trial registry maintained by the National Library of Medicine. NCT01941563 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.